Navigation Links
Vaccine for Alzheimer’s diseas

Researchers developing a vaccine against Alzheimer’s disease have shown that it seems to stop mice with the condition losing their memory. The results boost hopes that such vaccines could delay or prevent similar symptoms in people.

The vaccines reduces the build-up of protein deposits in mouse brains -the other major indicator of Alzheimer’s diseases. The pharmaceutical company Elan, based in Dublin, Ireland, is poised to begin human clinical trails of a potential treatment based on the vaccine.

Nearly one in ten people over the age of 65 suffers the dementia by Alzheimer’s disease, and the risk rises fourfold for those over 80. Several genes have been linked to the condition – particularly one that codes for a protein known as beta-amyloid peptide.

Mutations to this gene cause the protein to be over produced, forming the fibrous plagues in the brains of Alzheimer’s patients and killing the nerve cells.

When Alzheimer’s mice are vaccinated with beta-amyloid peptide they develop antibodies against the protein, which sweep the brain clean of the plagues.

Mice given the test vaccine developed fewer protein deposits in their brains compared with unvaccinated animals. These results are reported in Nature.

Whether the protein deposits actually cause dementia in people is something of an open question among Alzheimer’s researchers. However, the mouse models don’t seem to show the same neural destruction suffered by human patients. But it is certainly encouraging and one can hope that some kind of human application willfollow.
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Health Officials Recommend Flu Vaccine
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Panacea Biotech To Market Anthrax Vaccine
6. New Prostate Cancer Vaccine Shows Promise
7. Drug Firm Offers to Donate Smallpox Vaccine
8. Vaccine guards against shingles
9. Vaccine for septic conditions
10. A new Vaccine for Pneumonia
11. Vaccine Reduces antibiotic-resistant infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... , ... August 20, 2017 , ... Are you an ... household? If so, you may be interested in participating in a research study ... this research is to understand more about the relational aspects of adults who have ...
(Date:8/19/2017)... ... August 18, 2017 , ... President Donald Trump ... legislation that provides for greater public access to over-the-counter (OTC) hearing aids. , ... OTC hearing aids without being seen by a certified and licensed audiologist. ...
(Date:8/19/2017)... CA (PRWEB) , ... August 19, 2017 , ... Yesterday, ... the KKK by saying there are two sides. There are not two sides to ... way to rationalize violence and prejudice, and the NPEIV stands against all forms of ...
(Date:8/18/2017)... (PRWEB) , ... August 19, 2017 , ... ... Tourism Authority of Thailand presided over the Amazing Thailand Health and Wellness Tourism ... Thailand. , Mr. Noppadon Pakprot, Deputy Governor for Tourism Products and Business at ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , In ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... August 17, 2017 DarioHealth Corp. (NASDAQ: ... mobile health and big data solutions, announced today ... domestic and non-U.S. investors for the sale of ... of the Company,s newly designated Series B Convertible ... Company expects to conduct a closing with respect ...
(Date:8/15/2017)... WILMINGTON, N.C. , Aug. 15, 2017 ... Wilmington, NC , today announced that the company ... at the University of North Carolina at Chapel Hill ... AccuKit-HIV is designed to characterize and quantify HIV reservoir ... and after pharmacological intervention. The HIV Cure Center is ...
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
Breaking Medicine Technology: